Abbott India (BOM:500488) Change In Receivables : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Abbott India Change In Receivables?

Abbott India's change in receivables for the quarter that ended in Mar. 2024 was ₹0 Mil. It means Abbott India's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Abbott India's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-17 Mil. It means Abbott India's Accounts Receivable increased by ₹17 Mil from Mar. 2023 to Mar. 2024 .

Abbott India's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹3,191 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Abbott India's Days Sales Outstanding for the three months ended in Mar. 2024 was 20.24.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Abbott India's liquidation value for the three months ended in Mar. 2024 was ₹12,836 Mil.

Abbott India Change In Receivables Historical Data

The historical data trend for Abbott India's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Change In Receivables Chart

Abbott India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

-419.60

647.80

-391.70

-287.30

-16.80

Abbott India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Abbott India Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Abbott India (BOM:500488) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Abbott India's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3191.1	/	14386.3	*	91
=	20.24

2. In Ben Graham's calculation of liquidation value, Abbott India's accounts receivable are only considered to be worth 75% of book value:

Abbott India's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	22290.5	-	14946	+	0.75 * 3191.1	+	0.5 * 6195.8
=	12,836

Abbott India Change In Receivables Related Terms

Thank you for viewing the detailed overview of Abbott India's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott India (BOM:500488) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

ABBOTINDIA:India

Address

15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.abbott.co.in

Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines